Literature DB >> 6317148

Regulation of plasma 1,25-(OH)2-D3 by phosphate: evidence against a role for total or acid-soluble renal phosphate content.

R W Gray, M L Haasch, C E Brown.   

Abstract

In order to evaluate a possible role for tissue phosphate or phosphorylated compounds in mediating the increase in plasma 1,25-(OH)2-D3 levels during dietary phosphate deprivation, measurements of total and acid-soluble renal cortical phosphate content have been made in both intact and hypophysectomized (hypox) rats eating a normal diet and also after four days of dietary phosphate deprivation. Similar measurements were also made in phosphate-deprived hypophysectomized rats replaced with growth hormone (GH). Total and acid-soluble renal cortical phosphate content averaged 81 +/- 8 mumol/g and 4.1 +/- 0.6 mumol/g, respectively, in intact rats eating the normal diet and were not significantly altered after phosphate deprivation despite a fall in plasma phosphate of about 40% and a fourfold increase in plasma 1,25-(OH)2-D3 levels. Total and acid-soluble renal cortical phosphate content levels were higher in hypox rats, averaging 92 +/- 8 mumol/g and 4.9 +/- 0.7 mumol/g, respectively, but also did not change after phosphate deprivation. Replacement of phosphate-deprived hypox rats with GH resulted in a further fall in plasma phosphate and a significant increase in plasma 1,25-(OH)2-D3 levels, but there was no change in either total or acid-soluble renal cortical phosphate content. The distribution of organophosphorus compounds in the acid-soluble phosphate fraction in these experiments was also evaluated using 31P NMR spectrometry. Although there appeared to be an increase in the total concentration of organophosphorus compounds after phosphate deprivation, this effect was not altered by hypophysectomy or by replacement of phosphate-deprived hypox rats with GH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317148     DOI: 10.1007/bf02405122

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  11 in total

1.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion.

Authors:  L A Baxter; H F DeLuca
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

3.  The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

Authors:  Y Tanaka; H F Deluca
Journal:  Arch Biochem Biophys       Date:  1973-02       Impact factor: 4.013

4.  Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy.

Authors:  R W Gray
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

5.  Effects of age and sex on the regulation of plasma 1,25-(OH)2-D by phosphorus in the rat.

Authors:  R W Gray
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

6.  Growth hormone and triiodothyronine permit an increase in plasma 1,25(OH)2D concentrations in response to dietary phosphate deprivation in hypophysectomized rats.

Authors:  R W Gray; T L Garthwaite; L S Phillips
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

7.  The effects of diet and stool composition on the net external acid balance of normal subjects.

Authors:  E J Lennon; J Lemann; J R Litzow
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

8.  Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3.

Authors:  J I Rader; D J Baylink; M R Hughes; E F Safilian; M R Haussler
Journal:  Am J Physiol       Date:  1979-02

9.  Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat.

Authors:  M R Hughes; P F Brumbaugh; M R Hussler; J E Wergedal; D J Baylink
Journal:  Science       Date:  1975-11-07       Impact factor: 47.728

10.  Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse.

Authors:  R A Meyer; R W Gray; M H Meyer
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

View more
  3 in total

Review 1.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

2.  Response of tissue phosphate content to acute dietary phosphate deprivation in the X-linked hypophosphatemic mouse.

Authors:  C E Brown; C A Wilkie; M H Meyer; R A Meyer
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

Review 3.  The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Authors:  Ladan Zand; Rajiv Kumar
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.